(Q33541433)

27 July 2017

1 reference

title

Apoptosis of activated peripheral T cells (English)

1 reference

27 July 2017

Genestier L

1

1 reference

27 July 2017

Bonnefoy-Berard N

series ordinal

2

1 reference

27 July 2017

Revillard JP

series ordinal

3

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 February 1999

1 reference

Transplantation Proceedings

27 July 2017

published in

1 reference

27 July 2017

volume

31

1 reference

27 July 2017

issue

1-2A

1 reference

27 July 2017

page(s)

33S-38S

1 reference

Fas ligand mediates activation-induced cell death in human T lymphocytes

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Programmed cell death and extrathymic reduction of Vβ8+CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Peripheral deletion of antigen-reactive T cells in oral tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Fas (CD95) participates in peripheral T cell deletion and associated apoptosis in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Activation-induced death of mature T cells in the regulation of immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Induction of apoptosis in mature T cells by tumour necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95)

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

The receptor for the cytotoxic ligand TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

TRAIL/Apo-2-ligand-induced apoptosis in human T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Interleukin-1 beta converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infecti

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

T cell sensitivity to HLA class I-mediated apoptosis is dependent on interleukin-2 and interleukin-4

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Daxx, a novel Fas-binding protein that activates JNK and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Thiols prevent Fas (CD95)-mediated T cell apoptosis by down-regulating membrane Fas expression

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Activation-induced cell death in murine T cell hybridomas. Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Unimpaired thymic and peripheral T cell death in mice lacking the nuclear receptor NGFI-B (Nur77)

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur77.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Regulation of the Nur77 orphan steroid receptor in activation-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Cyclosporin A blocks apoptosis by inhibiting the DNA binding activity of the transcription factor Nur77.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

9-cis retinoic acid inhibition of activation-induced apoptosis is mediated via regulation of fas ligand and requires retinoic acid receptor and retinoid X receptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Proteasome regulation of activation-induced T cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Proteasome regulation of Fas ligand cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Activation interferes with the APO-1 pathway in mature human T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Induction of sensitivity to activation-induced death in primary CD4+ cells: a role for interleukin-2 in the negative regulation of responses by mature CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Inhibition of death receptor signals by cellular FLIP

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

FAP-1: a protein tyrosine phosphatase that associates with Fas

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Activation-dependent lymphocyte apoptosis induced by methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

A role for CD95 ligand in preventing graft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Apoptosis: potential for disease therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902079-X

7 January 2021

10.1016/S0041-1345(98)02079-X

Identifiers

DOI

1 reference

27 July 2017

1 reference